Contributor Disclosures for Facial Trauma, Zygomatic Complex Fractures
Role Name Disclosure Details
Author Zachary Segal, MD, Staff Physician, Department of Ophthalmology, Washington National Eye Center Nothing to discloseDetails
Coauthor W Scott McDonald, MD, Private Practice, Miami, Florida Nothing to discloseDetails
Coauthor Seth R Thaller, MD, DMD, FACS, FAAP, Professor, Chief, Department of Surgery, Division of Plastic Surgery, University of Miami School of Medicine Nothing to discloseDetails
Medical Editor James F Thornton, MD, Assistant Professor, Department of Plastic and Reconstructive Surgery, University of Texas Southwestern Nothing to discloseDetails
Pharmacy Editor Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine Nothing to discloseDetails
Managing Editor Jaime R Garza, MD, DDS, FACS, Consulting Staff, Private Practice Nothing to discloseDetails
CME Editor Nicolas (Nick) G Slenkovich, MD, Practice Director, Colorado Plastic Surgery Center at Swedish Medical Center Nothing to discloseDetails
Chief Editor Al Aly, MD, FACS, Consulting Surgeon, Iowa City Plastic Surgery Ethicon
QMP
Insorb Stapler
Insorb Stapler
Medicis
Details









Contributor:
Contributor Disclosure:
Zachary Segal, Author  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
W Scott McDonald, Coauthor  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
Seth R Thaller, Coauthor  The contributor discloses no conflict of interest. 









Contributor Disclosure


Contributor:
Contributor Disclosure:
James F Thornton, Medical Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Francisco Talavera

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication









Contributor Disclosure


Contributor:
Contributor Disclosure:
Jaime R Garza, Managing Editor  The contributor discloses no conflict of interest. 






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Nicolas (Nick) G Slenkovich

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Off label or investigational use of medication






 

CONTRIBUTOR DISCLOSURE FORM


Contributor Name:
Al Aly

 DECLARATION STATEMENT
I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
I and/or my spouse/partner have a financial interest/arrangement with one or more organization(s), including but not limited to the organization(s) supporting this activity, that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.
COMMERCIAL INTEREST
(Name of Organization)
Self
Spouse/
Partner
NATURE OF RELEVANT FINANCIAL RELATIONSHIP
What was received?*
For what role?**

Ethicon
Consulting feeConsulting 
QMP
RoyaltyBook royalty 
Insorb Stapler
Consulting feeConsulting 
Insorb Stapler
Ownership interestNone 
Medicis
Intellectual property rightsNone 
Off label or investigational use of medication